Lava Therapeutics N.V. (LVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LVTX | AZN | AMGN | GILD | BMY |
| Company | Lava Therapeutics N.V. | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 1.8100 | 157.16 | 388.50 | 131.10 | 66.12 |
| High | 1.8200 | 159.71 | 391.03 | 131.50 | 68.10 |
| Low | 1.6200 | 153.41 | 375.96 | 129.04 | 64.14 |
| Last | 1.7400 | 157.97 | 378.87 | 131.15 | 65.47 |
| Change | -0.0700 | -11.67 | -6.29 | +0.94 | +0.16 |
| Percent Change | -3.87% | -6.88% | -1.63% | +0.72% | +0.24% |
| Volume | 285,500 | 16,313,000 | 3,443,000 | 7,523,900 | 32,970,902 |
| 20-Day Average Volume | 131,750 | 3,613,895 | 2,379,490 | 6,430,095 | 12,200,771 |
| Previous | 1.8100 | 169.64 | 385.16 | 130.21 | 65.31 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6475 | 171.43 | 371.38 | 132.24 | 60.88 |
| 20-Day Raw Stochastic | 65.31% | 11.29% | 56.57% | 27.23% | 76.77% |
| 20-Day Relative Strength | 61.37 | 35.72 | 58.40 | 50.41 | 66.91 |
| Weighted Alpha | +38.19 | -4.91 | +30.77 | +7.62 | +44.29 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | 24% Sell | 88% Buy |
| Yesterday's Opinion | 100% Buy | 88% Sell | 100% Buy | 24% Sell | 88% Buy |
| Last Month's Opinion | 96% Buy | 24% Buy | 56% Buy | 40% Sell | 32% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.35% since 11/13/25 | -6.88% since 07/27/26 | +0.69% since 07/27/26 | +0.48% since 07/27/26 | +4.65% since 07/27/26 |
| Low | 1.6000 on 11/17/25 | 153.41 on 08/03/26 | 375.96 on 08/03/26 | 128.28 on 07/30/26 | 62.23 on 07/30/26 |
| High | 1.8250 on 11/18/25 | 175.04 on 07/29/26 | 398.00 on 07/28/26 | 136.26 on 07/28/26 | 68.10 on 08/03/26 |
| 1-Month | |||||
| %Chg | +16.78% since 10/20/25 | -19.05% since 07/02/26 | +1.26% since 07/02/26 | -0.09% since 07/02/26 | +12.63% since 07/02/26 |
| Low | 1.4500 on 10/22/25 | 153.41 on 08/03/26 | 353.95 on 07/15/26 | 127.61 on 07/23/26 | 56.49 on 07/06/26 |
| High | 1.8250 on 11/18/25 | 193.79 on 07/07/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 3-Month | |||||
| %Chg | +14.10% since 08/20/25 | -14.49% since 05/01/26 | +14.87% since 05/01/26 | -0.38% since 05/01/26 | +12.45% since 05/01/26 |
| Low | 1.4000 on 09/19/25 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.8250 on 11/18/25 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 68.10 on 08/03/26 |
| 6-Month | |||||
| %Chg | +31.82% since 05/20/25 | -14.30% since 02/03/26 | +11.90% since 02/03/26 | -8.47% since 02/03/26 | +16.93% since 02/03/26 |
| Low | 1.1800 on 05/30/25 | 153.41 on 08/03/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 1.8250 on 11/18/25 | 212.71 on 02/18/26 | 398.00 on 07/28/26 | 157.29 on 02/11/26 | 68.10 on 08/03/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 45,771 | 263,096,016 | 207,873,936 | 161,664,832 | 133,367,648 |
| Shares Outstanding, K | 26,305 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales, $M | 11,980,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income, $M | -25,110,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Qtr Sales, $M | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Qtr Income, $M | -7,190,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.50 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 11/06/25 | 2.63 on 07/27/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 2.04 on 07/30/26 |
| Latest Earnings Date | 03/27/26 | 11/05/26 | 08/04/26 | 08/04/26 | 10/29/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividend Date | N/A | 02/20/26 | 08/21/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.65 | 17.54 | 15.68 | 9.96 |